☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Community
PharmaShots Interview: Marc Meachem Shares Insight on the ViiV's 2021 Commitment to the Community
April 7, 2021
Member of COVID R&D Alliance Report the First Patient Enrollment in COMMUNITY Study
December 1, 2020
Nabriva's Xenleta (lefamulin) Receives FDA's Approval for the Treatment of Community-Acquired Bacterial Pneumonia in Adults
August 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
